| Laura Ann Hanaford, MED, LMHC, LCPC | |
|
57 Wingate St Unit 401, Haverhill, MA 01832-5759 | |
| (978) 241-4908 | |
| Not Available |
| Full Name | Laura Ann Hanaford |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 57 Wingate St Unit 401, Haverhill, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003149337 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Ann Hanaford, MED, LMHC, LCPC 19 Sylvan Rd, Scarborough, ME 04074-8851 Ph: (978) 269-4347 | Laura Ann Hanaford, MED, LMHC, LCPC 57 Wingate St Unit 401, Haverhill, MA 01832-5759 Ph: (978) 241-4908 |
News Archive
Researchers from Boston University School of Medicine (BUSM) have identified a gene expression marker that distinguishes smokers with lung cancer from smokers without the disease. The findings, reported in the March 1, 2007 advanced on-line edition of Nature Medicine, may have immediate clinical relevance and public health impact.
The majority of genes associated with nephrotic syndrome (NS) in humans also play pivotal roles in Drosophila renal function, a conservation of function across species that validates transgenic flies as ideal pre-clinical models to improve understanding of human disease, a Children's National Health System research team reports in a recent issue of Human Molecular Genetics.
A high percentage of the population could be endangering their health by taking herbal medicines without checking with a health professional first according to Peter Houghton, Professor in Pharmacognosy, King's College London.
Eisai Inc. and Morphotek®, Inc. announced today that the Medical Ethical Review Committee and Central Committee on Research Involving Human Subjects of the Netherlands cleared its Clinical Trial Application to test the investigational new drug MORAb-022 in a Phase I clinical trial that will include both normal healthy volunteers and subjects diagnosed with rheumatoid arthritis.
› Verified 2 days ago
Jennifer Simard, Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 Merrimack St, Haverhill, MA 01830 Phone: 978-373-1126 Fax: 978-373-6363 | |
Samantha Asmar, Counselor Medicare: Not Enrolled in Medicare Practice Location: 26 Parkridge Rd, Haverhill, MA 01835 Phone: 978-380-0825 | |
Desirae Messina, Counselor Medicare: Not Enrolled in Medicare Practice Location: 26 Parkridge Rd Ste 2b, Haverhill, MA 01835 Phone: 978-374-0414 | |
Frank Joseph Saracino, Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 Merrimack St, Haverhill, MA 01830 Phone: 978-373-1126 Fax: 978-373-6363 | |
Amanda L Cole, Counselor Medicare: Not Enrolled in Medicare Practice Location: 116 Summer St, Haverhill, MA 01830 Phone: 978-373-7010 | |
Ryan Paradise, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 Merrimack St, Haverhill, MA 01830 Phone: 978-373-1126 Fax: 978-373-6363 |